Sutro Biopharma, Inc.
Symbol: STRO (NASDAQ)
0.00
▼ (-100.00%) -0.910
Company Description:
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $0.9104
- Yesterday High: $0.9994
- Yesterday Low: $0.9
- Yesterday Volume: 774.85K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: Sutro Biopharma, Inc.
- Website: https://www.sutrobio.com
- Listed Date: 2018-09-27
- Location: SOUTH SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001382101
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $77.18M
- Round Lot: 100
- Outstanding Shares: 84.77M
- Asset Type: CS
RECENT FILINGS FOR STRO
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-26 | 4 | View |
| 2025-08-26 | 4 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-07-29 | SCHEDULE 13G/A | View |
| 2025-07-16 | SCHEDULE 13G/A | View |
| 2025-06-30 | SCHEDULE 13G | View |
| 2025-06-25 | 8-K | View |
| 2025-06-10 | 8-K | View |
| 2025-06-10 | 4 | View |
| 2025-06-10 | 4 | View |
| 2025-06-10 | 4 | View |
| 2025-06-10 | 4 | View |
| 2025-06-10 | 4 | View |
| 2025-06-10 | 4 | View |
| 2025-06-10 | 4 | View |
| 2025-06-10 | 4 | View |
| 2025-06-02 | 4 | View |
Latest News on STRO